Test Compendium is your definitive resource for detailed information on a wide array of diagnostic tests. Each entry in our compendium is meticulously cataloged to aid healthcare providers in selecting and interpreting the right tests for their patients.
Displaying 426 - 450 of 475
Concurrent DeepSight™ Comprehensive 523 genes Liquid Biopsy (Somatic) + Neovare Portfolio testing (Germline) Methodology Molecular Test Description Disease Solid tumors; Breast cancer, Ovarian cancer,
Concurrent DeepSight™ on Liquid + siPortfolio Multi-Omics™ on Tissue Methodology Molecular Test Description Disease Solid tumorsOn Tissue: siPortfolio Multi-Omics™ • NGS (500+ genes, TMB, MSI)
LymphoSight™ Test Description Probes/Genes IHC/CISH ALK1, BCL-1, BCL-2, BCL-6, BRAF, Bob1, CD2, CD3, CD4, CD5, CD7, CD8, CD10, CD15, CD20, CD21, CD23, CD25*, CD30, CD43, CD79a, CD138, C-MYC, EBV-LMP, Granzyme B, ICOS*, IgA, IgG, IgG4, IgM, Kappa, Ki-67, Lambda, LEF1*, Mum1, OCT2, Pax5, Perforin, PD-1, TIA1. *: Pending CISH: EBER, Kappa,
S-100 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes S100 IHC Disease Marker of schwann cells and melanocyte, nerve sheath tumors, melanoma, and Langerhans cell histiocytosisFamily
SMMS-1 Alternative Name Smooth Muscle Myosin, Heavy Chain, SMMHC Methodology Immunohistochemistry (IHC) Test Description Probes/Genes SMMS IHC Disease Distinguish benign breast lesions and carcinoma in
SOX-10 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes SOX-10 IHC Disease Melanoma marker, soft tissue tumors of neural crest originTranscription factor known to be crucial in the
SOX11 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes SOX11 IHC Disease Mantle cell lymphomaSOX11 is a transcription factor that is normally expressed in the fetal brain and has also
STAT6 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes stat6 IHC Disease Distinction of solitary fibrous tumorSignal transducer and activator of transcription (STAT) 6/Member of STAT
Synaptophysin Methodology Immunohistochemistry (IHC) Test Description Probes/Genes SYNAPT IHC Disease Identification of neuronal tumors and tumors with neuroendocrine differentiationA protein (38 kD),
TdT Methodology Immunohistochemistry (IHC) Test Description Probes/Genes TDT IHC Disease Differentiating precursor lymphoid neoplasms, from other small blue cell tumors. Identifying clusters of thymocytes
Thrombomodulin (TM) Methodology Immunohistochemistry (IHC) Test Description Probes/Genes THROM IHC Disease Mesothelioma, Squamous Cell Carcinoma, Urothelial Carcinoma.Also called CD141. Thrombomodulin
Thyroglobulin (TGB) Methodology Immunohistochemistry (IHC) Test Description Probes/Genes THYRO IHC Disease Classification of thyroid carcinomaLarge glycoprotein (MW 670K) produced by thyroid follicular
TIA-1 Alternative Name T-cell Intracytoplasmic Antigen Methodology Immunohistochemistry (IHC) Test Description Probes/Genes TIA1 IHC Disease Neoplasms of cytotoxic T cells or natural killer cellsTIA-I
TRAP Alternative Name Tartrate Resistant Acid Phosphatase Methodology Immunohistochemistry (IHC) Test Description Probes/Genes TRAP IHC Disease Hairy cell leukemia, mantle cell lymphoma, splenic marginal
Trichrome Methodology Special Stains Test Description Probes/Genes TRI SS Disease Collagen and smooth muscle in tumors, cirrhosisStains collagen blue
TTF-1 Alternative Name Thyroid Transcription Factor Methodology Immunohistochemistry (IHC) Test Description Probes/Genes TTF1 IHC Disease Distinguish primary and metastatic lung carcinoma from non lung
Uroplakin II Methodology Immunohistochemistry (IHC) Test Description Probes/Genes UROPII IHC Disease Urothelial lesions/Ovarian Brenner tumorTransmembrane protein expressed by urothelial lining cells (umbrella
Uroplakin III Methodology Immunohistochemistry (IHC) Test Description Probes/Genes UROPIII IHC Disease Urothelial lesions/Ovarian Brenner tumorTransmembrane protein expressed by urothelial lining cells
Vimentin Methodology Immunohistochemistry (IHC) Test Description Probes/Genes VIMENT IHC Disease fibrosarcomas, liposarcomas, malignant fibrous histocytomas, angiosarcomas, chondrosarcomas and lymphomasVimentin
WT-1 Alternative Name Wilms Tumor Methodology Immunohistochemistry (IHC) Test Description Probes/Genes WT1 IHC Disease Wilms tumor, mesothelioma, fallopian tube and ovarian serous carcinoma, metanephric
MMR Panel by IHC (MLH1, MSH2, MSH6, PMS2) Methodology Immunohistochemistry (IHC) Test Description Probes/Genes MLH1, MSH2, MSH6, PMS2 Disease Lynch syndrome, carcinomas of the rectum, colon, small intestine
Leukemia/Lymphoma Screen Methodology Flow cytometry Test Description Probes/Genes CD3, CD4, CD5, CD8, CD14, CD19, CD20, CD33, CD34, CD38, CD45, CD56, CD117, Kappa, Lambda Disease Anemia, leukopenia, leukocytosis,
Myelodysplastic syndrome (MDS) Flow Panel Methodology Flow cytometry Test Description Probes/Genes CD2, CD3, CD4, CD5, CD7, CD8, CD10, CD11b, CD13, CD14, CD15, CD16, CD19, CD33, CD34, CD36, CD38, CD45,
Acute leukemia Flow Panel Methodology Flow cytometry Test Description Probes/Genes CD2, cCD3, sCD3, CD4, CD5, CD7, CD8, CD10, CD11b, sCD13, cCD13, CD14, CD15, CD16, CD19, cCD22, CD33, CD34, CD36, CD38,
B-cell Acute Lymphoblastic Leukemia (B-ALL) Flow Panel Methodology Flow cytometry Test Description Probes/Genes CD2, cCD3, sCD3, CD4, CD5, CD7, CD8, CD10, CD11b, sCD13, cCD13, CD14, CD15, CD16, CD19, CD20,
T-cell Acute Lymphoblastic Leukemia (T-ALL) Flow Panel Methodology Flow cytometry Test Description Probes/Genes CD1a, CD2, cCD3, sCD3, CD4, CD5, CD7, CD8, CD10, CD11b, sCD13, cCD13, CD14, CD15, CD16, CD19,
Lymphoproliferative Disorder (LPD) FLow Panel Methodology Flow cytometry Test Description Probes/Genes CD2, CD3, CD4, CD5, CD7, CD8, CD10, CD11c, CD16, CD19, CD20, CD23, CD38, CD45, CD56, CD57, Kappa,
With core values rooted in service and integrity, our leadership team sets the bar high.
We consistently strive to set the model for exactly how a reference laboratory should engage with both physicians and patients.
siParadigm is accredited by CLIA (Clinical Laboratory Improvement Amendments) and certified by CAP (College of American Pathologists).
We also hold select state licensure where required.